Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01275729 · ClinicalTrials.gov registry record · NA
The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT01275729 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 96 participants.
The verdict
NCT01275729, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The primary objective is to safely determine if the investigators can identify the severity of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled the investigators will draw blood and urine for novel and standard biomarkers. The investigators are attempting to determine if these biomarkers can forecast the course of AKI (need for dialysis, death and renal recovery). The investigators seek to determine how well physicians caring for those with AKI can predict the clinical course compared to these novel biomarkers of AKI and if there is an association between clinical course and 3 year patient outcomes.
Interventions
- DRUG Furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2010-12 |
| Est. Completion | 2022-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01275729
The ClinicalTrials.gov registry entry for NCT01275729 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Furosemide is the first listed.
NCT01275729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01275729 about?
NCT01275729 is a clinical study titled "The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury". The primary objective is to safely determine if the investigators can identify the severity of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled the investigators will draw blood and urine for novel and standard biomarkers. The investigators are attempting to determine if t...
What is the current status of trial NCT01275729?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2010-12. Estimated completion is 2022-06.
What interventions are being tested in trial NCT01275729?
The interventions under investigation include: Furosemide (DRUG).
Who is sponsoring clinical trial NCT01275729?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.